Different mechanisms for changes in glucose uptake of the right and left ventricular myocardium in pulmonary hypertension

J Nucl Med. 2005 Jan;46(1):25-31.

Abstract

In patients with pulmonary hypertension (PH) the right ventricular (RV)-to-left ventricular (LV) ratio of fatty acid uptake is reduced. In animal studies, such a finding was combined with an increased glucose uptake in RV myocardium. The aim of this study was to measure the metabolic rates of glucose uptake for the RV and LV myocardium in patients in relationship to parameters of RV and LV function.

Methods: Thirty patients with PH underwent PET with (18)F-FDG and SPECT with (99m)Tc-tetrofosmine. The metabolic rate of glucose uptake was determined for RV and LV myocardium using the method of Patlak. A right heart catheter, thermodilution, and Doppler sonography were used to characterize RV and LV function. From these methods, the stroke work of both ventricles and the RV Tei index were calculated.

Results: RV-to-LV ratios of (18)F-FDG-uptake increased with rising pulmonary arteriolar resistance (PAR). With increasing PAR, the metabolic rate of glucose uptake of the left ventricle decreased (r = -0.547; P < 0.01) together with LV stroke work (r = -0.838; P < 0.001). The metabolic rate of glucose uptake of the right ventricle, however, correlated neither with RV stroke work (r = 0.124) nor with PAR (r = 0.189) but with the Tei index (r = 0.78; P < 0.001).

Conclusion: Increasing right-to-left ratios of glucose uptake with an increasing pressure load in the right ventricle in PH are caused mainly by a significant reduction in the LV metabolic rate of glucose uptake. This is obviously due to a reduced energy demand of the LV myocardium caused by reduced stroke work. An increased metabolic rate of glucose uptake in the right ventricle presumably indicates RV impairment, correlating with the Tei index, which is an established prognostic parameter for cardiac dysfunction and poor survival.

Publication types

  • Clinical Trial
  • Comparative Study

MeSH terms

  • Female
  • Fluorodeoxyglucose F18 / pharmacokinetics*
  • Glucose / pharmacokinetics
  • Heart Ventricles / diagnostic imaging
  • Heart Ventricles / metabolism
  • Humans
  • Hypertension, Pulmonary / complications
  • Hypertension, Pulmonary / diagnostic imaging*
  • Hypertension, Pulmonary / metabolism*
  • Male
  • Metabolic Clearance Rate
  • Middle Aged
  • Myocardium / metabolism
  • Radionuclide Imaging
  • Radiopharmaceuticals / pharmacokinetics
  • Ventricular Dysfunction, Left / diagnostic imaging*
  • Ventricular Dysfunction, Left / etiology
  • Ventricular Dysfunction, Left / metabolism*
  • Ventricular Dysfunction, Right / diagnostic imaging*
  • Ventricular Dysfunction, Right / metabolism*

Substances

  • Radiopharmaceuticals
  • Fluorodeoxyglucose F18
  • Glucose